MedPath

An Innovative Method Fluid-jet to to Remove Residual Lens Fibers

Not Applicable
Conditions
Posterior Capsule Opacification
Registration Number
NCT03605160
Lead Sponsor
Sun Yat-sen University
Brief Summary

Residual lens fibers (RLFs) on the posterior lens capsule during cataract surgery can cause after cataract, affecting visual quality and increasing the medical cost for further laser posterior capsulotomy. However, conventional polish is inconvenient and time-consuming. We use an innovative fluid-jet method to remove RLFs, and compare the efficacy of fluid-jet and polish to prevent posterior capsular opacity after phacoemulsification.

Detailed Description

Purpose: Residual lens fibers (RLFs) on the posterior lens capsule during cataract surgery can cause after cataract, affecting visual quality and increasing the medical cost for further laser posterior capsulotomy. However, conventional polish is inconvenient and time-consuming. We use an innovative fluid-jet method to remove RLFs, and compare the efficacy of fluid-jet and polish to prevent posterior capsular opacity after phacoemulsification.

Design: Single-center, prospective, randomized controlled clinical study Subjects of study: Age-related cataract patients receiving phacoemulsification from Zhongshan Ophthalmic Center, Guangzhou, China.

Methods: patients are 1: 1 randomized to two groups. Polish group: After irrigation and aspiration (I/A), the RLFs on the posterior capsule are removed by polishing before intraocular lens (IOL) implantation; Fluid-jet group: Polish is not performed. RLFs on posterior capsule are removed by jetting fluid with an irrigating syringe after IOL implantation. The posterior capsular images of all the patients are obtained immediately before and after IOL implantation, and at the end of surgery, then the amount of RLFs is quantitatively analyzed by using LYZ-PCO, a software we developed. Best corrected visual acuity and parameters of visual quality, such as objective scattering index(OSI), Strehl ratio (SR) and Modulation Transfer Function (Mtf)-cut off are evaluated by objective visual quality analyser (OQAS) at 1 day, 1 week and 1 year after surgery. The patients receives telephone follow-up every month. The severity of posterior capsular opacification (PCO) and incidence of laser posterior capsulotomy is recorded.

Main indicators for the study: The incidence of laser posterior capsulotomy a year after surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
740
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
change in rate of posterior capsulotomy1 year, 2 year, 3 year, 4 year, 5 year after surgery

Incidence rate of laser posterior capsulotomy

Secondary Outcome Measures
NameTimeMethod
area of posterior capsular opacification1 year, 2 year, 3 year, 4 year, 5 year after surgery

posterior capsular opacification area percentage

change in objective scattering index1 day, 1 week, 1 year post-op, and every year thereafter.

objective scattering index of participants

change in visual acuity1 day, 1 week, 1 year post-op, and every year thereafter.

Best corrected visual acuity tested with ETDRS chart

change in Strehl ratio1 day, 1 week, 1 year post-op, and every year thereafter.

Strehl ratio of participants

change in modulation transfer function cut off1 day, 1 week, 1 year post-op, and every year thereafter.

Modulation transfer function cut off of participants

residual lens fibersthe amount of residual lens fibers is to be measured for every participant using ocular image taken with surgical microscope at the end of the cataract surgery

amount of residual lens fibers at the posterior lens capsule

Trial Locations

Locations (1)

Zhognshan Ophthalmic Center, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

Zhognshan Ophthalmic Center, Sun Yat-sen University
🇨🇳Guangzhou, Guangdong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.